Glusense

Implantable Glucose level sensor for Type 1 Diabetes patients

placeLod, Central District, Israel calendar_todayFounded 2007 groups6 employees language glusensemedical.com

Registered entities

Innovation

13 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 1,696 times.

YearFilings
20122
20133
20142
20154
20163
20174
20181
20191
20202

Investor mix

17 investors on record; lead investors include T1D Fund, Ping An Ventures, Yongjin Group, ZTE.

Investor typeCountShare
Venture capital635%
Private equity16%
Other / undisclosed1059%
Coming soon